NCT01181102View on ClinicalTrials.gov

A Phase 3 Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty

PHASE3CompletedINTERVENTIONAL
Enrollment

716

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

September 30, 2009

Study Completion Date

February 28, 2010

Conditions
Venous Thromboembolism
Interventions
DRUG

edoxaban

DRUG

enoxaparin sodium

Trial Locations (3)

Unknown

Osaka

Tokyo

Kaohsiung City

Sponsors
All Listed Sponsors
lead

Daiichi Sankyo Co., Ltd.

INDUSTRY